IME Stock Overview
Offers cloud-based medical imaging solutions in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
ImExHS Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.36 |
| 52 Week High | AU$0.69 |
| 52 Week Low | AU$0.32 |
| Beta | 1.24 |
| 1 Month Change | -8.75% |
| 3 Month Change | -23.96% |
| 1 Year Change | -40.16% |
| 3 Year Change | -61.58% |
| 5 Year Change | -80.27% |
| Change since IPO | -72.96% |
Recent News & Updates
Investors Don't See Light At End Of ImExHS Limited's (ASX:IME) Tunnel And Push Stock Down 26%
Nov 28
ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks
Jun 27Recent updates
Investors Don't See Light At End Of ImExHS Limited's (ASX:IME) Tunnel And Push Stock Down 26%
Nov 28ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks
Jun 27Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet
Jan 02ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch
Jun 07Is ImExHS (ASX:IME) Using Too Much Debt?
Mar 09Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)
Mar 19Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?
Feb 11Shareholder Returns
| IME | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 2.1% | -0.7% | -2.7% |
| 1Y | -40.2% | 130.7% | 6.5% |
Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 130.7% over the past year.
Return vs Market: IME underperformed the Australian Market which returned 6.5% over the past year.
Price Volatility
| IME volatility | |
|---|---|
| IME Average Weekly Movement | 10.8% |
| Healthcare Services Industry Average Movement | 10.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: IME has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: IME's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 400 | German Arango | www.imexhs.com |
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis.
ImExHS Limited Fundamentals Summary
| IME fundamental statistics | |
|---|---|
| Market cap | AU$16.65m |
| Earnings (TTM) | -AU$3.42m |
| Revenue (TTM) | AU$24.90m |
0.7x
P/S Ratio-4.9x
P/E RatioIs IME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IME income statement (TTM) | |
|---|---|
| Revenue | AU$24.90m |
| Cost of Revenue | AU$14.92m |
| Gross Profit | AU$9.99m |
| Other Expenses | AU$13.41m |
| Earnings | -AU$3.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.075 |
| Gross Margin | 40.10% |
| Net Profit Margin | -13.73% |
| Debt/Equity Ratio | 5.8% |
How did IME perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ImExHS Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Iain Wilkie | Morgans Financial Limited |